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2Summary25
Long-chain polyunsaturated fatty acids (LC-PUFAs) are essential in important 26
physiological processes, many of which are particularly vital during embryonic 27
development. This study investigated the expression of genes encoding enzymes 28
involved in LC-PUFA biosynthesis, namely fatty acyl desaturase (Fad) and Elovl5- and 29
Elovl2-like elongases, during early embryonic development of zebrafish. Firstly, 30
zebrafish elovl2 cDNA was isolated and functionally characterised in yeast, showing 31
high specificity towards C20 and C22 PUFAs, compared to C18 substrates. Secondly, 32
spatial-temporal expression for elovl2 and the previously cloned fad and elovl5 were 33
studied during zebrafish early embryonic development. Temporal expression shows that 34
all three genes are expressed from the beginning of embryogenesis (zygote), suggesting 35
maternal mRNA transfer to the embryo. However, a complete activation of the 36
biosynthetic pathway seems to be delayed until 12 hpf, when noticeable increases of fad37
and elovl2 transcripts were observed, in parallel with high docosahexaenoic acid levels 38
in the embryo. Spatial expression was studied by whole-mount in situ hybridization in 39
24 hpf embryos, showing that fad and elovl2 are highly expressed in the head area 40
where neuronal tissues are developing. Interestingly, elovl5 shows specific expression 41
in the pronephric ducts, suggesting an as yet unknown role in fatty acid metabolism 42
during zebrafish early embryonic development. The yolk syncytial layer also expressed 43
all three genes, suggesting an important role in remodelling of yolk fatty acids during 44
zebrafish early embryogenesis. Tissue distribution in zebrafish adults demonstrates that 45
the target genes are expressed in all tissues analysed, with liver, intestine and brain 46
showing the highest expression.47
3Introduction48
Long-chain polyunsaturated fatty acids (LC-PUFAs) are essential compounds that play 49
key roles in numerous metabolic and physiological processes ensuring normal cellular 50
function. Some LC-PUFAs, including arachidonic (20:4n-6, ARA) and 51
eicosapentaenoic (20:5n-3, EPA) acids, are precursors of eicosanoids, biologically 52
active compounds that modulate physiological processes including inflammation, 53
reproduction and hemostasis [1]. Increased dietary levels of n-3 LC-PUFAs including 54
EPA and docosahexaenoic acid (DHA, 22:6n-3) have being described as health 55
promoters related to cardiovascular, immune, and inflammatory conditions [2,3]. 56
Additionally LC-PUFAs are constituents of cell membrane phospholipids, determining 57
in part fluidity, and activity of membrane proteins and enzymes involved in transport 58
and signal transduction [4]. This is critical in neuronal tissues where a unique degree of 59
fluidity and compressibility of cell membranes is provided by DHA-rich phospholipids 60
that enable rapid conformational changes required for neurotransmission and 61
photoreception [5].62
    The biosynthesis of LC-PUFAs in vertebrates involves consecutive desaturation and 63
elongation reactions that convert the essential fatty acids (EFAs) 18:3n-3 (?-linolenic 64
acid) and 18:2n-6 (linoleic acid) to longer-chain, more unsaturated fatty acids (FAs) of 65
the same series, including EPA, DHA and ARA (Fig. 1, [6,7]). Two types of enzymes 66
are responsible for these conversions, namely fatty acyl desaturases (Fad) and elongases 67
of very long fatty acids (Elovl). The former introduce a double bond in the fatty acyl 68
chain at C6 (?6 Fad) or C5 (?5 Fad) from the carboxyl group. On the other hand, Elovl 69
account for the condensation of activated FAs with malonyl-CoA in the FA elongation 70
pathway. Several members of the Elovl family are involved in PUFA biosynthesis in 71
mammals, those being Elovl5 with substrate specificity for C18 FAs and Elovl2 for C20 72
4and C22 [8,9]. Additionally, Elovl4 has been speculated to participate in the elongation 73
steps required for synthesis of DHA in mammalian retina [9].74
    The importance of LC-PUFA in developing organisms is illustrated by their accretion 75
in neuronal tissues during embryogenesis [10-15]. Additionally, deficient production of 76
LC-PUFAs during development can cause neuromuscular defects, cuticle abnormalities, 77
reduced brood size, and altered biological rhythms in Caenorhabditis elegans mutants 78
that lack fat-3, the gene for ?6 desaturase [16]. In mammals, it has been suggested that79
LC-PUFAs are preferentially delivered from the mother to the fetus by transfer across 80
the placenta since fetal LC-PUFA biosynthetic capacity appears to be limited [12,17]. In 81
oviparous organisms such as avians, FAs present in yolk in the form of triacylglycerol 82
or phospholipid molecules are absorbed into the yolk sac membrane for delivery into 83
the embryonic circulation and utilisation for energy, membrane biogenesis, and fat 84
deposition [18]. Amounts of LC-PUFAs deposited by the hen are insufficient to fulfil 85
the requirements of the embryo, and therefore biosynthesis of LC-PUFA by the chicken 86
embryo is, contrary to human fetus, very active in order to compensate such a 87
deficiency [19,20].88
    In fish, studies have demonstrated that supply of LC-PUFAs to embryos is greatly 89
influenced by the diet of broodstock [21,22], and that suboptimal levels of LC-PUFA 90
delivered to larvae may compromise ability to capture prey in herring (Clupea 91
harengus) [23], delay response to visual stimuli in gilthead sea bream (Sparus aurata) 92
[24], and impair schooling behaviour in yellowtail (Seriola quiqueradiata) [25,26] and 93
Pacific threadfin (Polydactylus sexfilis) [27]. Despite the known importance of LC-94
PUFA supply during embryonic development and their proven selective accumulation 95
in certain lipid classes [28], little is known about the capability of fish embryos for 96
endogenous biosynthesis to supplement preformed LC-PUFA present in the yolk.97
5    Significant progress has been made in characterising the desaturases and elongases 98
involved in LC-PUFA synthesis in fish including freshwater [29-33] and marine species 99
[34-38]. Zebrafish (Danio rerio), a popular model organism in vertebrate developmental 100
biology, has recently been used to study aspects of lipid metabolism [39-42]. Two 101
enzymes involved in LC-PUFA biosynthesis have been characterised in zebrafish, a Fad 102
????? ????? ?????? ????????? ??????? ?????? ???????????? ?????? ???? ??? ????????? ????? ?????103
specificity towards C18 and, to a lesser extent, C20 PUFA [30], similar to elongases 104
found in several other fish species [31-32]. Recently, a cDNA for a second elongase 105
was isolated from salmon and shown to have high specificity towards C20 and C22 106
PUFA [33]. 107
    The present study aimed to investigate the expression of Fad and Elovl enzymes 108
involved in LC-PUFA biosynthesis during early development of zebrafish. Firstly, we 109
isolated and functionally characterised a second zebrafish elongase cDNA important in 110
the biosynthesis of DHA. Secondly, the spatial-temporal expression pattern of the newly 111
cloned elongase, together with the previously isolated Fad [43] and elongase [30], was 112
investigated during zebrafish embryogenesis. Expression of these three enzymes enable 113
zebrafish to synthesise all LC-PUFA from C18 EFA, and therefore zebrafish are an 114
excellent model to study early developmental regulation of LC-PUFA synthesis in 115
vertebrates.116
117
Materials and methods118
119
Fish maintenance120
Adult AB wild-type zebrafish strain were maintained at the facilities of the Instituto de 121
Investigaciones Marinas (IIM-CSIC) as described previously [44]. Zebrafish embryos 122
6collected from mating of single broodstock couples were isolated and raised at 28.5ºC 123
and staged according to the number of hours post-fertilization (hpf) [43]. For whole-124
mount in situ hybridization analyses, dechorionated embryos were fixed overnight at 4 125
ºC in 4 % paraformaldehyde in 1xPBS, washed in PBS, and dehydrated through a 126
methanol series, and stored at -20 ºC in 100 % methanol. To inhibit embryo 127
pigmentation, embryo medium was supplemented with 0.003 % 1-phenyl-2-thiourea 128
(PTU, Sigma, Alcobendas, Spain) [44]. 129
130
Zebrafish Elovl2: cloning and functional characterization by heterologous expression in 131
Saccharomyces cerevisiae132
PCR fragments corresponding to the ORF of the putative Elovl2 elongase 133
(gb|NP_001035452|) were amplified from zebrafish liver cDNA using specific primers 134
containing restriction sites (underlined) – Elovl2VF 135
(CCCAAGCTTAGGATGGAATCATATGAAAAAATTGATAAG; HindIII) and 136
Elovl2VR (CCGCTCGAGTCACTGTAGCTTCTGTTTGGAG; XhoI). PCR was 137
performed using the high fidelity PfuTurbo? DNA polymerase (Stratagene, Agilent 138
Technologies, Cheshire, UK), with an initial denaturing step at 95 ºC for 2 min, 139
followed by 35 cycles of denaturation at 95ºC for 30 s, annealing at 57 ºC for 30 s, 140
extension at 72 ºC for 1 min 10 s, followed by a final extension at 72 ºC for 5 min. The 141
DNA fragments were then digested with the corresponding restriction endonucleases 142
(New England BioLabs, Herts, UK) and ligated into a similarly restricted pYES2 yeast 143
expression vector (Invitrogen, Paisley, UK). The purified plasmids (GenElute™ 144
Plasmid Miniprep Kit, Sigma) containing the putative Elovl2 ORF were then used to 145
transform S. cerevisiae competent cells (S.c. EasyComp Transformation Kit, 146
Invitrogen). Transformation and selection of yeast with recombinant pYES2-elovl2147
7plasmids, yeast culture and FA analysis was performed as described in detail previously 148
[28,41,44]. Briefly, cultures of recombinant yeast were grown in S. cerevisiae minimal 149
medium-uracil supplemented with one of the following FA substrates: stearidonic acid 150
(18:4n-3), ?-linolenic acid (18:3n-6), EPA (20:5n-3), ARA (20:4n-6), docosapentaenoic 151
acid (22:5n-3) or docosatetraenoic acid (22:4n-6). Docosapentaenoic and 152
docosatetraenoic acids (>98-99% pure) were purchased from Cayman Chemical Co. 153
(Ann Arbor, USA) and the remaining FA substrates (>99% pure) and chemicals used to 154
prepare the S. cerevisiae minimal medium-uracil were from Sigma Chemical Co. Ltd. 155
(Dorset, UK). FAs were added to the yeast cultures at final concentrations of 0.5 (C18), 156
0.75 (C20) and 1.0 (C22) mM. After 2-days, yeast were harvested and washed, and lipid 157
extracted by homogenization in chloroform/methanol (2:1, v/v) containing 0.01% BHT 158
as antioxidant. FA methyl esters were prepared, extracted, purified, and analysed by GC 159
in order to calculate the proportion of substrate FA converted to elongated FA product 160
as [product area/(product area +substrate area)] x 100. Identities of FA peaks were 161
based on GC retention times and confirmed by GC-MS as described previously [30,43].162
163
Sequence and phylogenetic analysis of Elovl2164
The amino acid (AA) sequence deduced from the zebrafish Elovl2 cDNA 165
(gb|NP_001035452|) was compared with human (gb|NP_060240|), mouse 166
(gb|NP_062296|) and rat (gb|NP_001102588|) ELOVL2s, amphibian Xenopus laevis167
(gb|NP_001087564|) and X. tropicalis (gb|NP_001016159|) Elovl2s, bird Taenopygia 168
guttata (gb|XP_002186815.1|) and Gallus gallus (gb|XP_418947|) predicted Elovl2-like 169
proteins, and salmon Elovl2 (gb|FJ237532|) using the EMBOSS Pairwise Alignment 170
Algorithms tool (http://www.ebi.ac.uk/Tools/emboss/align/). A phylogenetic tree was 171
constructed on the basis of the AA sequence alignments between the putative zebrafish 172
8Elovl2, Elovl2 orthologs and Elvol5 proteins, and using the Neighbour Joining method 173
[47]. Confidence in the resulting phylogenetic tree branch topology was measured by 174
bootstrapping through 1000 iterations.175
176
Temporal expression of fad, elovl5, elovl2 during zebrafish ontogeny177
To study the expression of the target genes during the embryonic development of 178
zebrafish, total RNA was extracted from pools of 20-30 embryos collected at 0, 3, 6, 9, 179
12, 14, 24, 48, and 72 hpf using Tri Reagent (Sigma) according to manufacturer’s 180
protocol. Five !g of total RNA was reverse transcribed into cDNA using M-MLV 181
reverse transcriptase first strand cDNA synthesis kit (Promega, Madison, USA). 182
Qualitative expression of fad, elovl5 and elovl2 transcripts during embryonic 183
development was determined by reverse transcriptase PCR (RT-PCR) on cDNA 184
samples, with an initial denaturing step at 95 ºC for 2 min, followed by 35 cycles of 185
denaturation at 95 ºC for 30 s, annealing at 60 ºC for 30 s, and extension at 72 ºC for 1 186
min 40 s, followed by a final extension at 72 ºC for 5 min. Expression of ?-actin was 187
also determined as reference gene [48]. Primers used for RT-PCR on embryos cDNA 188
samples are shown in Table 1.189
190
Spatial expression of fad, elovl5, elovl2, whole-mount in situ hybridization191
To examine the spatial expression of zebrafish fad, elovl5 and elovl2, whole-mount in 192
situ hybridization (WISH) was performed on 24 hpf zebrafish embryos using 193
digoxygenin (DIG)-labelled antisense riboprobes as previously described [49]. 194
Antisense riboprobes were made from linerarised full length Danio rerio fad, elovl5 and 195
elovl2 cDNAs.196
197
9Tissue distribution of fad, elovl5 and elovl2 mRNA transcripts in zebrafish adults198
Expression of the target genes was also measured in adult tissues by quantitative real-199
time PCR (qPCR). Total RNA from eye, gill, liver, brain, ovary, testis, kidney, muscle, 200
intestine and adipose tissue was extracted as described above, and 1 !g of total RNA 201
reverse transcribed into cDNA (M-MLV reverse transcriptase, Promega). The qPCR 202
was performed using primers shown in Table 1. Copy numbers of target genes were 203
normalised with copy number of the reference gene 18s rRNA [48]. PCR amplicons of 204
each gene were cloned into pBluescript II KS (Stratagene) that was then linearised, 205
quantified spectrophotometrically (NanoDrop ND-1000, Thermo Scientific,206
Wilmington, USA), and serial-diluted to generate a standard curve of known copy 207
numbers. The qPCR amplifications were carried out in triplicate using a Quantica 208
machine (Techne, Cambridge, UK) in a final volume of 20 !l containing 5 !l diluted 209
(1/10) cDNA, 0.5 !M of each primer and 10 !l AbsoluteTM QPCR SYBR® Green mix 210
(ABgene, Epsom, UK). Amplifications were carried out with a systematic negative 211
control (NTC - no template control, containing no cDNA). The qPCR profiles contained 212
an initial activation step at 95 °C for 15 min, followed by 40 cycles: 15 s at 95 °C, 15 s 213
at the specific primer pair annealing Tm (Table 1) and 10-15 s at 72 °C. After the 214
amplification phase, a dissociation curve of 0.5 ºC increments from 75 ºC to 90 °C was 215
performed, enabling confirmation of the amplification of a single product in each 216
reaction. The qPCR product sizes were checked by agarose gel electrophoresis and their 217
identity confirmed by sequencing. No primer-dimer formation occurred in the NTC. All 218
reactions were carried out in triplicate and a linear standard curve was drawn, and 219
absolute copy number of the targeted gene in each sample was calculated.220
221
Fatty acid analyses of zebrafish embryos222
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In order to monitor the FA changes during embryogenesis, pools of 150-200 embryos 223
were sampled at different stages (0, 9, 24, 48 and 72 hpf) and total lipid extracted, FA 224
methyl esters prepared and analysed as described above.225
226
Statistics227
For tissue expression profiles, results expressed as mean normalised values (? SE) 228
corresponding to the ratio between the copy numbers of fad, elovl5 and elovl2 229
transcripts and the copy numbers of the reference gene, 18s rRNA. A one-way analysis 230
of variance (ANOVA) followed by Tukey HSD test (P<0.05) was performed to 231
compare the expression level among tissue samples (SPSS, Chicago, USA). 232
233
Results234
235
Zebrafish elongase (Elovl2) sequence and phylogenetics236
The new zebrafish elongase ORF encodes a protein of 295 AA, sharing 73.6 % identity 237
in AA sequence to the salmon Elovl2, 65.8 - 68.1 % AA identity to mammalian 238
homologues, and 66.9 - 68.4 % identity with predicted Elovl2 sequences from 239
amphibians and birds. The phylogenetic tree (Fig. 2) shows that zebrafish Elovl2 240
elongase clusters most closely with salmon Elovl2, the only Elovl2 elongase cloned and 241
characterised in fish so far. The fish Elovl2 elongases cluster with the mammalian, 242
amphibian and bird Elovl2-like elongases, and more distantly from Elovl5-like 243
elongases from mammals and fish.244
245
Functional characterisation246
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The zebrafish putative Elovl2 elongase was functionally characterised by determining 247
the FA profiles of S. cerevisiae transformed with pYES2 containing elovl2 cDNA ORF 248
insert and grown in the presence of potential FA substrates. The FA composition of the 249
wild yeast consists essentially of 16:0, 16:1n-7, 18:0 and 18:1n-9 [43]. Control 250
treatments consisting of yeast transformed with pYES2 vector without elongase insert 251
contained these FA together with whichever exogenous FA was added as substrate (data 252
not shown), this result being consistent with the well established lack of PUFA elongase 253
activity in S. cerevisiae [30,32]. Zebrafish Elovl2 shows activity towards FA substrates 254
from 18 to 22 carbons, with the highest specificity on C20 and C22 substrates (Table 2). 255
The traces show the major endogenous FA (16:0. 16:1n-7, 18:0 and 18:1n-9) and 256
additional peaks corresponding to the substrate and elongation products (Fig. 3). Thus 257
exogenously added 18:4n-3 (Fig. 3A) and 18:3n-6 (Fig. 3B) were elongated to their 258
corresponding C20, C22 and C24 elongation products 20:4n-3, 22:4n-3 and 24:4n-3 259
(from 18:4n-3) and 20:3n-6, 22:3n-6 and 24:3n-6 (from 18:3n-6). Total conversion of 260
C18 substrates ranged from 20.1 - 23.0 % (Table 2). Higher elongation rates were 261
observed for C20 substrates 20:5n-3 (78.4 %) and 20:4n-6 (65.3 %), being elongated to 262
C22, C24 and C26 products (Fig. 3C-D). Elovl2 also elongated C22 FA substrates to 263
C24 and C26 elongation products. Thus, yeast transformed with pYES2-elovl2264
converted 22:5n-3 to 24:5n-3 and 26:5n-3 (Fig. 3E), and 22:4n-6 was elongated to 265
24:4n-6 and 26:4n-6 (Fig. 3F). Comparison of peak areas of the endogenous fatty acids 266
in yeast indicates Elovl2 shows some capability to elongate monounsaturated fatty acids 267
such as 16:1n-7 to 18:1n-7 (5.2 - 7.0 %) and 18:1n-9 to 20:1n-9 (1.5 - 3.1 %). No 268
evidence for elongation of saturated FAs was observed with the zebrafish Elovl2.269
270
Spatial-temporal expression of fad, elovl5 and elovl2 in zebrafish271
12
Temporal expression of fad, elvol5 and elovl2 was studied by RT-PCR on cDNA 272
samples obtained from embryos at different developmental stages from 0 to 72 hpf (Fig. 273
4). Results reveal that all three genes are expressed from the zygote stage (0 hpf), with 274
transcripts detected throughout embryonic development. Although comparisons of 275
transcript levels from RT-PCR analyses have to be made cautiously, some temporal 276
patterns can be observed in the expression of fad, with a noticeable increasing 277
expression from 12 hpf onwards. Also obvious was the pattern shown by elovl2, which 278
showed low expression until 9 hpf, with evident increased expression during 12 to 72 279
hpf. Changes in expression of elovl5 with development were less obvious, and ?-actin280
reference gene expression was constant during development of zebrafish embryos.281
    To examine the spatial expression of zebrafish fad, elovl5 and elovl2, WISH was 282
performed on 24 hpf zebrafish embryos (Fig. 5). Zebrafish fad (Fig. 5B) and elovl2283
transcripts (Fig. 5F) were widely distributed in the head region and specifically in the 284
yolk syncytial layer (YSL) (Fig. 5B, F insets). Similar to the expression patterns of 285
zebrafish fad and elovl2, zebrafish elovl5 was also uniformly expressed in the YSL (Fig. 286
5D inset). However, unlike fad and elovl2, elovl5 was specifically expressed in the 287
pronephric ducts of 24 hpf embryos (Fig. 6D). Embryos treated with control sense 288
probes did not show any signal (Fig. 5A, C, E).289
    Adult tissue distribution of fad, elvol5 and elovl2 mRNA transcripts was analysed by 290
qPCR (Fig. 6). Results indicate that these genes are expressed in all tissues analysed, 291
with significantly higher levels of these transcripts found in liver than any other tissue. 292
Although no significant differences were found, intestine and brain also showed high 293
levels of transcripts, especially fad and elovl2. Muscle and gill appear to be tissues with 294
very low expression of the three genes. Generally speaking, expression of zebrafish fad295
gene was higher than those of elongase genes. 296
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297
Fatty acid composition of zebrafish embryos298
Activity of the enzymes involved in LC-PUFA biosynthesis during zebrafish 299
embryogenesis was estimated by comparing levels of C18 substrates (18:3n-3 and 300
18:2n-6) with levels of all potential desaturation/elongation products (Fig. 7). Total 301
amount of C18 precursors decreased by around 50% over the time-course of 302
embryogenesis, and the levels of products of the biosynthetic pathway showed a steady 303
increase as development proceeded (Fig. 7). Contents of DHA, the most abundant 304
PUFA in zebrafish embryos, initially decreased until 9 hpf, and then increased until the 305
end of embryonic development. The fatty acid profiles (!g of fatty acid per mg of total 306
lipid) of zebrafish embryos at different stages of development are shown in Table 3.307
308
Discussion309
Our overall objective is to elucidate the molecular mechanisms controlling LC-PUFA 310
synthesis in vertebrates. Using zebrafish as a model species, the specific aim of the 311
present study was to determine the ontogenic changes in expression of genes of the LC-312
PUFA synthesis pathway during development. In order to do this, we examined all the 313
key genes of LC-PUFA synthesis pathway. Previously, we cloned a Fad cDNA from 314
zebrafish that was unique among vertebrate Fads in showing dual ?6/?5 activity [43]. 315
The enzyme product displayed all the fatty acyl desaturation activities required for the 316
synthesis of EPA and DHA [50]. Subsequently, a PUFA elongase cDNA was also 317
isolated from zebrafish [30]. In mammals, ELOVL2 and ELOVL5 have been shown to 318
participate in LC-PUFA biosynthesis [8,9,51,52]. Mammalian ELOVL5 is 319
predominantly involved in the elongation of C18 and C20 PUFA, whereas ELOVL2 has 320
greatest activity in the elongation of C20 and C22 PUFA and, therefore, appears to be a 321
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critical enzyme for the synthesis of C22 and C24 LC-PUFAs [6,8, 51,52]. Functional 322
characterisation showed the first cloned zebrafish PUFA elongase [28] to be similar to 323
elongases found in several other fish species [31,32,38], now all designated as Elovl5 324
[33]. In contrast to mammalian Elovl5s, fish Elovl5s displayed C22 elongation activity, 325
albeit low, and so it was speculated that ?6/?5 Fad and Elovl5 were the only desaturase 326
and elongase necessary for LC-PUFA synthesis in zebrafish [50]. However, whereas 327
sequence similarity searches against the zebrafish draft genome assembly (Zv7)328
revealed no further Fad genes, a further elongase-like gene was present in chromosome 329
24 that, if expressed, could potentially participate in LC-PUFA production. We now 330
report the cDNA cloning and functional characterisation of this second zebrafish 331
elongase (gb|NP_001035452|).332
    The AA sequence of the newly cloned zebrafish elongase shows high identity to the 333
recently cloned salmon elongase cDNA, which has been shown to be an Elovl2 334
orthologue [33], and relatively high identity to mammalian ELOVL2s. Phylogenetic 335
analysis groups the zebrafish elongase into a cluster with greatest similarity to salmon 336
Elovl2 and other Elovl2-like genes from mammals, amphibians and birds, and more 337
distantly from Elovl5 elongases. Functional characterisation of the zebrafish cDNA 338
confirms that the encoded protein elongated C20 and C22 PUFA and so the elongase is 339
designated as an Elovl2. Recombinant yeast containing zebrafish Elovl2 cDNA also 340
produced C26 PUFA from their corresponding C20 and C22 substrates, although these 341
conversions are unlikely to occur in vivo because of competition with ??? ???? ????342
intermediate C24 PUFAs [6]. As described for mouse and salmon, zebrafish elovl2343
cDNA encodes an enzyme that also has C18-20 elongase activity [8,33]. This is in 344
contrast to human ELOVL2, which is only active towards C20 and C22 substrates [8]. 345
Importantly, the major difference in comparison to zebrafish Elovl5 [30] and other fish 346
15
Elovl5s, is the high activity towards C22 PUFA shown by zebrafish Elovl2. Therefore, 347
Elovl2 is a key component in the biosynthesis of DHA, where two consecutive 348
elongation steps from 20:5n-3 to 22:5n-3 and 22:5n-3 to 24:5n-3 are required, followed 349
by ??? ????????????? ???? ?????-shortening [6,53]. These results prove that zebrafish 350
possess all the enzymatic activities required for LC-PUFA synthesis [6], with ?6 and ?5 351
desaturation performed by a single protein [43], and elongation of PUFAs ranging from 352
C18 to 22 catalysed by Elovl5 [30] and the herein characterised Elovl2. The capability 353
of zebrafish for LC-PUFA biosynthesis was previously assessed in isotopic studies with 354
primary hepatocytes showing that the pathway for EPA and DHA synthesis was fully 355
functional [54]. This conclusion is supported by the molecular cloning of the ?6/?5 Fad 356
[43], Elovl5 [30], and the newly characterised Elovl2.357
    Expression of all Fad and Elovl activities required for LC-PUFA biosynthesis, 358
presents zebrafish as an excellent model to study relationships between expression of 359
these genes and important developmental events where high demands for LC-PUFA are 360
required, especially the formation of neuronal tissues critical for the viability of the 361
embryo [10,16]. In humans, such high requirements for LC-PUFAs are mostly delivered 362
to the fetus by transfer across the placenta, since fetus LC-PUFA biosynthesis capability 363
has been suggested to be insufficient [17]. Similar to avians, where embryos have been 364
demonstrated to biosynthesise LC-PUFA [55], our results suggest that LC-PUFA 365
biosynthesis occurs in zebrafish embryos, as supported by the presence of fad, elovl5366
and elovl2 transcripts during embryogenesis, and the dynamic FA composition of 367
embryos denoting endogenous production of LC-PUFA.368
    Temporal expression patterns show that genes of LC-PUFA biosynthesis enzymes in 369
zebrafish are detected at the zygote stage (0 hpf). The only explanation for this is that 370
maternal transfer of the target gene mRNA takes place in zebrafish, since zygotic gene 371
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activation is delayed until midblastula transition, which begins at the 512 cell stage at 372
2.75 hpf [45]. This highlights that the maternal role in LC-PUFA supply to fish embryos 373
is not only transfer of preformed LC-PUFA [21,22], but also transfer of mRNA 374
transcripts that can potentially be translated to active proteins. Expression of fad, elovl5375
and elovl2 genes continues to the end of embryogenesis (72 hpf), and so the pathway 376
could be active throughout to assure the high demands of forming tissues such as brain 377
and retina for LC-PUFAs.378
    Beyond maternal mRNA transfer and its potential role in LC-PUFA biosynthesis in 379
early stage embryos, the results raise the question of when the embryo itself begins to 380
activate the pathway. Despite the steady increase in total LC-PUFA content during 381
embryogenesis, DHA initially decreases from 0 to 9 hpf. This could indicate that, 382
although mRNA transcripts of fad, elovl5 and elovl2 were detected during the early 383
developmental stages (0-9 hpf), the biosynthesis pathway is not fully active, at least for 384
producing C22 PUFAs. Supporting this idea is the fact that elovl2 mRNA transcripts are 385
very low until 9 hpf, possibly limiting biosynthesis of specifically DHA during early 386
embryogenesis [8]. From 9 hpf onwards de novo transcription of embryonic genes likely 387
occurs as indicated by increased levels of fad and elovl2 transcripts from 12 hpf. We 388
may speculate that the increase in expression of fad and elovl2 is due to the 389
development of the central nervous system and retina, occurring in zebrafish at 390
gastrula:bud (10.0 - 10.33 hpf) and 5-9 somites (11.66 - 14.0 hpf), respectively [45]. 391
The spatial expression of fad and elovl2 in zebrafish embryos supports this hypothesis.392
    Spatial expression patterns of FA metabolism enzymes in zebrafish was first studied 393
by Hsieh and co-workers [56], who determined that stearoyl-CoA desaturase, the 394
enzyme responsible for the synthesis of 18:1n-9 from 18:0, is evenly expressed in all 395
embryo tissues. A more specific expression has now been observed for genes encoding 396
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enzymes of the LC-PUFA biosynthesis pathway, with fad and elovl2 genes highly 397
expressed in the head area of zebrafish embryos, probably related to the requirement for 398
ARA and DHA in developing neuronal tissues [10-17]. Interestingly, the Elovl5 399
elongase was specifically expressed in the pronephric ducts of 24 hpf embryos. 400
Although Elovl5 elongase has been reported to be expressed in kidney of adult fish 401
[33,36,46], there is no obvious explanation for such a specific expression in the 402
pronephric ducts of the embryonic kidney, and further investigations are required to 403
elucidate these findings.404
    The spatial gene expression data also reveals that the yolk syncytial layer (YSL) may 405
also be an important tissue for embryonic LC-PUFA biosynthesis in zebrafish. The 406
YSL, a structure unique to teleosts, forms a boundary layer between the embryo and the 407
yolk mass. Consequently, all nutrients contained in the yolk must pass through the YSL 408
before being utilised by the developing tissues in the embryo [57]. Indeed the presence 409
of proteolytic enzyme activities in teleost YSL has been reported previously, in 410
agreement with an active role in resorption of yolk lipoproteins [58,59]. Our results 411
show that YSL is likely also to be active in remodelling PUFA during zebrafish 412
embryogenesis. Thus, in addition to hydrolysis of the abundant lipids contained in the 413
yolk [60], the YSL may also influence the composition of the hydrolysed and absorbed 414
FA in a number of ways including conversion of C18 FA and alteration of EPA/DHA 415
ratio prior to transfer to the developing embryonic tissues. As aforementioned, retinal 416
membranes are composed by DHA-rich phospholipids [61,62], and therefore LC-PUFA 417
biosynthetic activity could be expected in developing eye. However, no clear expression 418
of fad, elvol5 and elovl2 genes in retina was detected in the present study. Previously, 419
zebrafish embryo retina/eye tissue was found to express Elovl4 elongase [63], 420
speculated to be a photoreceptor-specific component of the LC-PUFA biosynthesis 421
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pathway [9]. Recently it was shown that Elovl4 was required for the production of C28-422
C38 very long chain PUFA in retina, brain and sperm [64], and is implicated in the 423
synthesis of very long chain omega-hydroxylated fatty acids present in ceramides of the 424
epidermal permeability barrier in mammals [65].425
    The present study also demonstrates that adult zebrafish expressed ?6/?5 fad, elovl5426
and elovl2 genes in all tissues analysed. In agreement with previous studies on 427
freshwater fish, our results show that the genes in zebrafish are predominantly 428
expressed in liver, intestine and brain implicating these tissues as the most active in LC-429
PUFA biosynthesis [33,46]. This is consistent with liver and intestine being the major 430
sites of lipid synthesis and distribution. Furthermore, liver and intestine have been 431
described to be the primary tissues for LC-PUFA synthesis in salmonids [66,67].432
Comparison of transcript levels indicates that fad expression is consistently higher than 433
that of both elongases. This could be related to the fact that zebrafish Fad, having dual 434
??????????????????????????????????????????????????????????????????????-PUFA biosynthesis 435
[43].436
    In conclusion the present study demonstrates that zebrafish Elovl2 shows substrate 437
specificity towards C20- and C22-PUFA, indicating its important role in synthesis of 438
LC-PUFA, particularly DHA. All three genes, fad, elovl5 and elovl2, are ubiquitously 439
expressed in adult zebrafish tissues with highest expression levels in liver, intestine and 440
brain. Our results demonstrate the presence of fad, elovl5 and elovl2 transcripts from the 441
zygote stage indicating that maternal transfer of mRNA occurs in zebrafish. Subsequent 442
increases of fad and elovl2 transcript levels however, suggest endogenous embryonic 443
expression is activated at later stages when required for neuronal tissues development. 444
DHA levels during zebrafish embryogenesis and spatial expression of fad and elovl2445
support this hypothesis. The WISH data also indicated that other tissues such as YSL 446
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and the pronephric ducts have roles in LC-PUFA metabolism in early embryogenesis in 447
D. rerio. Whereas the role of YSL appears obvious in remodelling of yolk FA, the role 448
of the pronephric ducts is both intriguing and obscure and requires further investigation.449
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Legends to Figures655
Fig. 1. Biosynthesis pathways of long-chain polyunsaturated fatty acids from C18 656
precursors, 18:3n-3 and 18:2n-6 [6].657
658
Fig. 2. Phylogenetic tree comparing the putative zebrafish Elovl2, Elovl2 orthologs and 659
Elvol5 proteins The tree was constructed using the Neighbour Joining method [47] 660
using MEGA4. The horizontal branch length is proportional to amino acid substitution 661
rate per site. The numbers represent the frequencies (%) with which the tree topology 662
presented was replicated after 1000 iterations.663
*Predicted proteins (GenBank).664
665
Fig. 3. Functional characterisation of the zebrafish putative elongase Elovl2 in 666
transgenic yeast (Saccharomyces cerevisiae) grown in the presence of fatty acid 667
substrates 18:4n-3 (A), 18:3n-6 (B), 20:5n-3 (C), 20:4n-6 (D), 22:5n-3 (E) and 22:4n-6 668
(F). Fatty acids were extracted from yeast transformed with pYES2 vector containing 669
the ORF of the putative elongase cDNA as an insert. Peaks 1-4 represent the main 670
endogenous FAs of S. cerevisiae, namely 16:0 (1), 16:1n-7 (2), 18:0 (3) and 18:1n-9 (4). 671
Substrates (“*”) and their corresponding elongated products are indicated accordingly in 672
panels A-F. Vertical axis, FID response; horizontal axis, retention time.673
674
Fig. 4. RT-PCR analyses of the temporal expression patterns of fad, elvol5, and elovl2675
during zebrafish Danio rerio embryogenesis (0 to 72 hpf at 28.5 ºC). Expression of the 676
housekeeping gene ?-actin is also shown. hpf, hours post-fertilization; NTC, no 677
template control.678
679
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Fig. 5. Whole mount in situ hybridization showing the expression of fad (A, B), elovl5680
(C, D), and elovl2 (E, F) in 24 hpf embryos. Embryos were hybridised with either sense 681
(A, C, D) or antisense probes (B, D, F). Strong signal was observed in the head region 682
and yolk syncytial layer (B, F inset) of 24-hpf embryos when antisense fad and elovl2683
probes were used (A), but no signal was observed for sense probe (E). Similar results 684
were observed for elovl5 (C, D), however, its expression was specifically localised in 685
the pronephric ducts (D) and the yolk syncytial layer (D inset). Lateral views, dorsal 686
upward, anterior to the left (A-F). YSL, yolk syncytial layer; PD, pronephric ducts; H, 687
??????????????????????????????????688
689
Fig. 6. Tissue distribution of the fad, elovl5 and elovl2 transcripts (mRNA) in zebrafish 690
adults. Absolute copy numbers were quantified for each transcript and were normalised 691
by absolute levels of 18s RNA. Results are means ± S.E. (n = 3). L, liver; I, intestine; B, 692
brain; E, eye; K, kidney; A, adipose; M, muscle; O, ovary; T, testis; G, gill. * P < 0.05 693
as determined by one-way ANOVA and Tukey’s test.694
695
Fig. 7. Fatty acid contents during zebrafish embryogenesis. Contents (!g of fatty acid 696
per mg of total lipid) of substrates (sum of 18:3n-3 and 18:2n-6) and potential products 697
(sum of 18:4n-3, 18:3n-6, 20:3n-3, 20:4n-3, 20:2n-6, 20:3n-6, 20:5n-3, 20:4n-6, 22:4n-698
3, 22:5n-3, 22:6n-3, 22:4n-6, 24:5n-3, 24:4n-6, 24:6n-3 and 24:5n-6) of long-chain 699
polyunsaturated fatty acid biosynthesis enzymes Fad, Elovl5 and Elovl2. Levels of 700
docosahexaenoic acid (DHA; 22:6n-3) are also shown.701
Table 1. Sequence and annealing temperature (Tm) of the primer pairs used, size of the fragment produced and accession number of the 
sequence used as reference for primer design, for Elovl2 ORF cloning, reverse transcriptase PCR (RT-PCR) performed in embryo samples, and 
quantitative real time PCR (qPCR) determinations of transcripts in adult tissues. 
Aim Transcript Primer Primer sequence Fragment Tm Accession No1.
ORF cloning elovl2 Elovl2VF 5’-CCCAAGCTTAGGATGGAATCATATGAAAAAATTGATAAG-3’ 184 bp 60ºC NM_001040362
Elovl2VR 5’-CCGCTCGAGTCACTGTAGCTTCTGTTTGGAG-3’
RT-PCR fad FadF1 5’-AGGAGGTGCAGAAACACACC-3’ 1264 bp 60ºC AF309556
FadR1 5’-CTCGCCAGATTTCTCCAAAG -3’
elovl5 Elovl5F1 5’-CTCAGGGTCACAGGATGGTT-3’ 768 bp 60ºC NM_200453
Elovl5R1 5’-CTCCATTAGTGTGGCCGTTT-3’
elovl2 Elovl2F1 5’-AAAGAGATACCCGCGTGAGA-3’ 810 bp 60ºC NM_001040362
Elovl2R1 5’-TTGGAGTTGGCTCCGTTTAG-3’
?-actin ?-ActinF1 5’-CTCTTCCAGCCTTCCTTCCT-3’ 246 bp 60ºC NM_131031
?-ActinR1 5’-CACCGATCCAGACGGAGTAT-3’
qPCR fad FadF2 5’-CATCACGCTAAACCCAACA-3’ 158 bp 60ºC AF309556
FadR2 5’-GGGAGGACCAATGAAGAAGA-3’
elovl5 Elovl5F2 5’-TGGATGGGACCGAAATACAT-3’ 173 bp 60ºC NM_200453
Elovl5FR2 5’-GTCTCCTCCACTGTGGGTGT-3’
elovl2 Elovl2F2 5’-CACTGGACGAAGTTGGTGAA-3’ 184 bp 60ºC NM_001040362
Elovl2R2 5’-GTTGAGGACACACCACCAGA-3’
18s 18sF1 5’-CCGCTATTAAGGGTGTTGGA-3’ 134 bp 62ºC NM_173234
18sR1 5’- GGCGAGGGTTCTGCATAATA-3’
1 GenBank (http://www.ncbi.nlm.nih.gov/)
Table1
Table 2. Functional characterisation of the newly characterised Elovl2 elongase.
Results are expressed as a percentage of total fatty acid (FA) substrate converted to 
elongated product. Percentage of stepwise conversion into intermediary products of 
the elongation pathway is also shown.
FA Substrate Product % Conversion Activity
18:4n-3 20:4n-3 6.0 C18?20
22:4n-3 7.0 C20?22
24:4n-3 10.0 C22?24
26:4n-3 0.0 C24?26
Total: 23.0
18:3n-6 20:3n-6 7.1 C18?20
22:3n-6 4.2 C20?22
24:3n-6 8.8 C22?24
26:3n-6 0.0 C24?26
Total: 20.1
20:5n-3 22:5n-3 7.7 C20?22
24:5n-3 63.1 C22?24
26:5n-3 7.6 C24?26
Total: 78.4
20:4n-6 22:4n-6 3.9 C20?22
24:4n-6 52.2 C22?24
26:4n-6 9.2 C24?26
Total: 65.3
22:5n-3 24:5n-3 43.2 C22?24
26:5n-3 11.0 C24?26
Total: 54.2
22:4n-6 24:4n-6 34.1 C22?24
26:4n-6 9.3 C24?26
Total: 43.4
Table2
!aaabbbllleee       333...       FFFaaattttttyyy       aaaccciiiddd       cccooommmpppooosssiiitttiiiooonnn       ooofff       zzzeeebbbrrraaafffiiissshhh       eeemmmbbbrrryyyooosss       aaattt       dddiiiffffffeeerrreeennnttt       ssstttaaagggeeesss       ooofff      dddeeevvveeelllooopppmmmeeennnttt...      RRReeesssuuullltttsss      aaarrreee      eeexxxppprrreeesssssseeeddd      iiinnn      µµµggg      ooofff      fffaaattttttyyy      aaaccciiiddd      pppeeerrr      mmmggg      ooofff      tttoootttaaalll      llliiipppiiiddd...      
Fatty acid 0 hpf 9 hpf 24 hpf 48 hpf 72 hpf
14:0 2.3 5.1 5.1 4.4 3.2
15:0 1.2 2.0 2.1 1.4 1.7
16:0 141.2 130.8 120.7 121.4 122.8
18:0 53.6 47.3 42.5 41.4 42.2
20:0 0.0 0.5 0.6 1.0 1.2
Total saturated 198.4 185.6 171.1 169.6 171.0
16:1n-9 3.5 3.4 3.4 3.3 3.7
16:1n-7 8.2 18.6 18.0 14.1 12.2
18:1n-9 87.6 93.1 85.5 80.1 81.8
18:1n-7 18.9 24.8 24.3 21.6 19.6
20:11 3.0 5.3 6.8 4.3 3.2
22:12 0.0 3.1 3.8 0.0 0.0
24:1n-9 0.0 0.4 0.5 0.3 0.3
Total monounsaturated 121.3 148.7 142.4 123.8 120.8
18:2n-6 41.5 21.8 22.7 23.5 17.6
18:3n-6 0.0 0.7 0.8 0.8 0.6
20:2n-6 2.5 1.5 1.8 1.7 1.9
20:3n-6 4.9 3.5 3.9 4.1 4.8
20:4n-6 11.7 14.2 15.6 16.3 16.3
22:4n-6 1.5 0.9 0.9 1.0 1.3
22:5n-6 1.0 4.1 4.2 5.1 5.1
Total n-6 PUFA 63.0 46.7 50.0 52.4 47.6
18:3n-3 3.2 4.5 3.4 3.1 2.6
18:4n-3 0.0 0.8 1.0 0.0 0.6
20:3n-3 0.0 1.0 0.9 0.8 0.9
20:4n-3 1.1 3.1 2.5 2.5 2.1
20:5n-3 19.3 44.4 43.4 41.3 42.9
22:5n-3 5.9 13.0 15.9 11.9 13.3
22:6n-3 91.5 63.1 74.4 86.1 89.7
Total n-3 PUFA 121.0 129.9 141.4 145.7 152.1
C16 PUFA 0.0 4.2 3.0 3.8 3.6
Total PUFA 184.1 180.8 194.4 201.9 203.3
111 ppprrreeedddooommmiiinnnaaannntttlllyyy      nnn-­‐-­‐-999      iiisssooommmeeerrr;;;      222 ppprrreeedddooommmiiinnnaaannntttlllyyy      nnn-­‐-­‐-111111      iiisssooommmeeerrr;;;      PPPUUUFFFAAA,,,      pppooolllyyyuuunnnsssaaatttuuurrraaattteeeddd      fffaaattttttyyy      aaaccciiiddd;;;      hhhpppfff,,,      hhhooouuurrrsss      pppooosssttt-­‐-­‐-fffeeerrrtttiiillliiizzzaaatttiiiooonnn
Table3
18:3n-3 
18:4n-3 
20:4n-3 
20:5n-3 
22:5n-3 
24:5n-3 
24:6n-3 
22:6n-3 
partial !-oxidation 
18:2n-6 
18:3n-6 
20:3n-6 
20:4n-6 
22:4n-6 
24:4n-6 
24:5n-6 
22:5n-6 
"6 desaturase 
"5 desaturase 
"6 desaturase 
elongase 
elongase 
elongase 
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Figure 3 (revised)
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